Financial Highlights

Category 2024 2023 2022 2021 2020 2019
FINANCIAL POSITION
Fixed assets net3,552,249,9523,051,888,2202,244,062,5821,734,765,860814,458,386735,519,503
Total assets11,402,428,6429,984,164,6148,127,152,4986,499,162,7372,471,348,5981,318,273,103
Paid - up Capital2,284,612,0002,284,612,0002,284,612,0001,350,000,000450,000,000450,000,000
Equity5,633,129,4415,373,073,3104,713,978,3284,366,045,1094,366,045,109978,308,204
Long term liabilities-8,541,062402,853,766297,605,788241,961,797139,515,252
STATEMENT OF PROFIT OR LOSS
Net Sales12,409,238,74212,396,982,5219,779,879,9385,795,403,9973,527,625,0002,607,027,951
Gross Profit1,586,195,1161,507,112,9781,363,082,659780,474,326436,949,856330,755,595
Operating Profit/(Loss)1,205,641,2531,167,477,796993,483,374570,970,333254,114,103136,427,404
Profit/(Loss) before tax1,281,201,708957,254,3441,060,576,110499,746,398202,527,899136,427,404
Profit/(Loss) after tax833,463,846657,984,360653,692,059351,768,295143,416,46827,804,462
PROFITABILITY RATIOS
Gross Profit %12.78%12.16%13.94%13.47%12.39%12.69%
Net Profit Ratio6.72%5.31%6.68%6.07%4.07%1.07%
RETURN TO SHAREHOLDER
Return on Capital Employed22.55%21.11%19.42%13.08%25.97%16.34%
Earning per share - Basic3.652.882.883.6431.876.18
LIQUIDITY / LEVERAGE
Current Ratio1.31.481.8592.4531.1141.169
Break up Value Per Share (With Revaluation)47.5723.5220.6332.34217.4185.49
Break up Value Per Share (Without Revaluation)24.0022.1619.2830.05217.4185.49
Debt To Equity Ratio70%29%21%15%46%39%
ACTIVITY
Sales to total assets0.881.241.200.891.431.98
Sales to fixed assets2.64.064.363.344.333.54

KEY OPERATING &
FINANCE DATA FOR LAST SIX YEARS

FINANCIAL POSITION
2026
2025
2024
2023
2022
2021
Fixed assets net
9,214,525,540
8,687,898,852
3,552,249,952
3,051,888,220
2,244,062,582
1,734,765,860
Total assets
18,119,626,067
18,439,450,481
11,402,428,642
9,984,164,614
8,127,152,498
6,499,162,737
Paid - up Capital
2,284,612,000
2,284,612,000
2,284,612,000
2,284,612,000
2,284,612,000
1,350,000,000
Equity
10,826,180,087
10,867,578,681
5,633,129,441
5,373,073,310
4,713,978,328
4,366,045,109
Long term liabilities
57,237,478
-
-
8,541,062
402,853,766
297,605,788
STATEMENT OF PROFIT OR LOSS
2026
2025
2024
2023
2022
2021
Net Sales
14,004,608,262
13,153,521,857
12,409,238,742
12,396,982,521
9,779,879,938
5,795,403,997
Gross Profit
2,449,584,700
2,017,608,317
1,586,195,116
1,507,112,978
1,363,082,659
780,474,326
Operating Profit/(Loss)
1,925,361,183
1,604,248,261
1,205,641,253
1,167,477,796
993,483,374
570,970,333
Profit/(Loss) before tax
1,331,337,205
1,354,509,829
1,281,201,708
957,254,344
1,060,576,110
499,746,398
Profit/(Loss) after tax
782,596,681
892,038,933
833,463,846
657,984,360
653,692,059
351,768,295
PROFITABILITY RATIOS
2026
2025
2024
2023
2022
2021
Gross Profit
17.49%
15.34%
12.78%
12.16%
13.94%
13.47%
Net Profit Ratio
5.59%
6.78%
6.72%
5.31%
6.68%
6.07%
RETURN TO SHAREHOLDER
2026
2025
2024
2023
2022
2021
Return on Capital Employed
15%
15%
22.55%
21.11%
19.42%
13.08%
Earning per share- Basic
3.43
3.90
3.65
2.88
2.88
3.64
LIQUIDITY/LEVERAGE
2026
2025
2024
2023
2022
2021
Current Ratio
1.26
1.30
1.36
1.48
1.859
2.453
Break up Value Per Share (With Revaluation)
47.39
47.57
24.66
23.52
20.63
32.34
Break up Value Per Share (Without Revaluation)
23.82
24.00
23.30
22.16
19.28
30.05
Debt To Equity Ratio
67%
70%
25%
29%
21%
15%
ACTIVITY
2026
2025
2024
2023
2022
2021
Sales to total assets
0.77
0.88
1.09
1.24
1.20
0.89
Sales to fixed assets
1.51
2.06
3.49
4.06
4.36
3.34
CITI PHARMA
LIMITED